These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6685483)

  • 41. Psychotomimetic drugs: biochemistry and pharmacology.
    Brimblecombe RW
    Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
    [No Abstract]   [Full Text] [Related]  

  • 42. Stereospecific actions of 2,5-dimethoxy-4-methylamphetamine (DOM) on colonic temperature in the rat at various ambient temperatures.
    Beaton JM; Benington F; Bradley RJ; Kuhlemeier KV; Morin RD
    Br J Pharmacol; 1976 Aug; 57(4):547-50. PubMed ID: 134754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 2,5-Dimethoxy-4-methylamphetamine (DOM)- a central component of its cardiovascular effects in rats; involvement of serotonin.
    Friedman E; Lambert GA; Buchweitz E
    Eur J Pharmacol; 1978 May; 49(2):157-61. PubMed ID: 26578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Steric and electronic relationships among some hallucinogenic compounds.
    Kang S; Green JP
    Proc Natl Acad Sci U S A; 1970 Sep; 67(1):62-7. PubMed ID: 5272329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dependent behavior. Pharmacologic aspects of drugs].
    Kutsch Lojenga JC
    Ned Tijdschr Geneeskd; 1978 Oct; 122(40):1509-11. PubMed ID: 211451
    [No Abstract]   [Full Text] [Related]  

  • 46. QSAR studies on phenylalkylamines interacting with the serotonin receptor.
    Gupta SP; Singh P; Bindal MC
    Farmaco Sci; 1982 Aug; 37(8):566-70. PubMed ID: 7128813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photoelectron spectra of psychotropic drugs. 6. Relationships between the physical properties and pharmacological actions of amphetamine analogues.
    Domelsmith LN; Eaton TA; Houk KN; Anderson GM; Glennon RA; Shulgin AT; Castagnoli N; Kollman PA
    J Med Chem; 1981 Dec; 24(12):1414-21. PubMed ID: 7310818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lysergic acid diethylamide: dissociation of its behavioral and hyperthermic actions by DL-alpha-methyl-p-tyrosine.
    Horita A; Hamilton AE
    Science; 1969 Apr; 164(3875):78-9. PubMed ID: 5773714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct quantitative analysis of lysergic acid diethylamide (LSD) and 2, 5-dimethoxy-4-methylamphetamine (STP) on thin-layer chromatograms.
    Niwaguchi T; Inoue T
    J Chromatogr; 1976 Jun; 121(1):165-9. PubMed ID: 932131
    [No Abstract]   [Full Text] [Related]  

  • 50. Interactions of metergoline with diazepam, quipazine, and hallucinogenic drugs on a conflict behavior in the rat.
    Commissaris RL; Rech RH
    Psychopharmacology (Berl); 1982; 76(3):282-5. PubMed ID: 6808551
    [No Abstract]   [Full Text] [Related]  

  • 51. The possible role of tryptamine in brain function and its relationship to the actions of LSD-like hallucinogens.
    Martin WR; Sloan JW
    Mt Sinai J Med; 1974; 41(2):276-82. PubMed ID: 4544624
    [No Abstract]   [Full Text] [Related]  

  • 52. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
    Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
    Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
    [No Abstract]   [Full Text] [Related]  

  • 53. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)-and (2,5-dimethoxy-4-ethylphenyl)isopropylamine.
    Jacob P; Shulgin AT
    J Med Chem; 1983 May; 26(5):746-52. PubMed ID: 6842515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effects of stereoisomers of psychotomimetic phenylisopropylamines.
    Dyer DC; Nichols DE; Rusterholz DB; Barfknecht CF
    Life Sci; 1973 Oct; 13(7):885-96. PubMed ID: 4766265
    [No Abstract]   [Full Text] [Related]  

  • 56. Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane.
    Standridge RT; Howell HG; Gylys JA; Partyka RA; Shulgin AT
    J Med Chem; 1976 Dec; 19(12):1400-4. PubMed ID: 1003425
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of behavioral properties of di- and tri-methoxyphenylisopropylamines.
    Glennon RA; Young R
    Pharmacol Biochem Behav; 1982 Oct; 17(4):603-7. PubMed ID: 6965276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pharmacological comparison of 3-methoxy-4,5-methylenedioxyamphetamine and LSD in the dog.
    Nozaki M; Vaupel DB; Bright LD; Martin WR
    Drug Alcohol Depend; 1978 May; 3(3):153-63. PubMed ID: 668489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MDA: an agent that produces stimulus effects similar to those of 3,4-DMA, LSD and cocaine.
    Glennon RA; Young R
    Eur J Pharmacol; 1984 Mar; 99(2-3):249-50. PubMed ID: 6145599
    [No Abstract]   [Full Text] [Related]  

  • 60. Structure-activity correlations for psychotomimetics. 1. Phenylalkylamines: electronic, volume, and hydrophobicity parameters.
    Clare BW
    J Med Chem; 1990 Feb; 33(2):687-702. PubMed ID: 2299636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.